Browse the evidence

High estrogen levels decrease tendon stiffness by inhibiting lysyl oxidase activity, which may protect muscles from eccentric injury but can negatively impact performance by reducing power output.

High estrogen levels make your tendons more compliant, which can protect your muscles from strain injuries during exercise. However, this same compliance might reduce your power output. Balance your training to account for these changes.

High-level occupational physical activity is associated with an 18% increased risk of all-cause mortality in men compared to low-level occupational activity, a finding attributed to the 'physical activity paradox' where occupational demands differ detrimentally from leisure-time activity.

If your job involves heavy manual labor, standing for long periods, or repetitive strain, be aware that this specific type of activity may increase your long-term mortality risk compared to sedentary office work, even if you are physically fit. To mitigate this, prioritize leisure-time activities that focus on cardiovascular fitness and recovery, rather than just adding more physical exertion. Current general physical activity guidelines may not adequately protect those in physically demanding jobs.

Activation of SIRT1 reduces hepatic steatosis by deacetylating and inhibiting lipogenic transcription factors SREBP-1c and ChREBP, while simultaneously enhancing fatty acid beta-oxidation via PPARalpha/PGC-1alpha signaling.

SIRT1 is a metabolic sensor that helps the liver manage fat. It works by turning down fat production genes and turning up fat-burning genes. While activating SIRT1 (e.g., via calorie restriction or specific compounds) shows protective effects in animal models, it is not a standalone cure. The primary driver of fatty liver remains the imbalance of lipid acquisition (diet/alcohol) versus removal.

Total daily energy expenditure (TEE) in traditional hunter-gatherers is not significantly different from that of Western populations when controlling for body size, challenging the model that decreased energy expenditure is a primary driver of modern obesity.

Do not assume that being sedentary automatically means your body burns significantly fewer calories than an active person of the same size. Your metabolism is robust and adapts to your body size and lean mass. Focusing solely on 'burning calories' through exercise may be less effective than managing energy intake, as your body's total daily expenditure is largely constrained by your physiology rather than just your activity level.

Wrist-worn fitness monitors (Apple Watch, Fitbit Charge HR, Samsung Gear S, Mio Alpha) provide accurate heart rate measurements but significantly underestimate energy expenditure, rendering them unreliable for weight management via energy balance tracking.

Do not rely on wrist-worn fitness trackers to dictate your calorie intake for weight loss. While they are good at tracking heart rate, they consistently underestimate calories burned by up to 43%. Use them for general activity trends, but do not use the calorie numbers to justify eating back exercise calories.

Acute moderate-intensity exercise does not significantly alter postprandial ghrelin levels in normal-weight subjects, suggesting ghrelin is not the primary driver of exercise-induced appetite suppression.

Don't blame ghrelin for your hunger (or lack thereof) after a moderate workout. Your body uses other signals (PYY, GLP-1) to manage appetite.

Vitamin D supplementation does not significantly improve glycaemic control (HbA1c) or insulin resistance in patients with normal fasting glucose, and provides only a small, likely clinically insignificant reduction in fasting glucose for those with diabetes or impaired glucose tolerance.

If you have diabetes or pre-diabetes, taking Vitamin D supplements is unlikely to significantly lower your blood sugar or HbA1c levels. While there might be a tiny reduction in fasting glucose for some, it is not clinically significant enough to rely on as a treatment. Focus on proven methods like diet, exercise, and prescribed medication instead.

Chronic oxidative stress and the resulting accumulation of oxidized, carbonylated proteins drive the loss of proteostasis and trigger cellular senescence, a primary mechanism of aging.

Focus on reducing chronic oxidative stress through a nutrient-dense diet rich in antioxidants (micronutrients, trace elements) and maintaining metabolic health to support proteostasis. This may help delay the onset of cellular senescence and age-related diseases.

Chronic high-fructose consumption promotes hepatic de novo lipogenesis (DNL) and intrahepatic lipid accumulation primarily by bypassing rate-limiting glycolytic steps and activating transcription factors ChREBP and SREBP1c, leading to increased VLDL secretion and dyslipidemia.

Fructose metabolism uniquely stimulates liver fat production through specific biological pathways (ChREBP/SREBP1c). However, human studies show that if you replace other calories with fructose without gaining weight (isocaloric), your liver fat may not increase more than if you ate those other calories. The real danger of fructose is that it contributes to excess calorie intake and weight gain. Focus on total caloric balance first; reducing high-fructose corn syrup and added sugars is a smart move for weight management, but don't assume fructose alone causes fatty liver if you are in a caloric deficit.

Fasting plasma concentrations of alpha-hydroxybutyrate (a-HB) and linoleoyl-glycerophosphocholine (L-GPC) serve as independent, early metabolic markers for predicting the development of dysglycemia and type 2 diabetes, with high a-HB and low L-GPC levels indicating increased risk.

If you are at risk for type 2 diabetes, standard fasting glucose tests might miss early metabolic changes. Emerging research suggests that specific metabolites (alpha-hydroxybutyrate and linoleoyl-glycerophosphocholine) can predict the development of diabetes earlier than standard tests. While not yet routine, these markers reflect underlying insulin resistance and beta-cell stress, suggesting that early metabolic profiling could allow for earlier lifestyle or medical interventions before glucose levels become abnormal.

The extent to which health behaviors (smoking, diet, physical activity, alcohol) explain socioeconomic differences in mortality is contingent on the strength of the social patterning of those behaviors; in contexts where unhealthy behaviors are strongly concentrated in lower socioeconomic groups, they act as major mediators of mortality inequality, whereas in contexts with weaker social patterning, they explain a minor proportion of the inequality.

If you are designing public health policy to reduce health inequalities, do not assume that promoting healthy behaviors (like quitting smoking or eating well) will automatically close the gap between rich and poor. The effectiveness of these behaviors in reducing inequality depends on how strongly those behaviors are linked to social status in your specific community. In places where unhealthy behaviors are concentrated among the poor, promoting them is a high-leverage strategy. In places where these behaviors are more evenly distributed, other structural factors may be more important.

Calcium supplementation does not negatively impact long-term iron status, despite short-term studies showing reduced iron absorption.

You can take calcium supplements without worrying about causing iron deficiency, even if you take them with meals. Long-term studies show that calcium does not harm your iron status, despite some short-term studies showing reduced absorption in a single meal.

In primary prevention clinical practice across Europe, less than half of treated hypertensive and dyslipidaemic patients achieve target blood pressure and lipid levels, and only one-third of treated diabetic patients achieve the HbA1c target.

If you are being treated for high blood pressure, high cholesterol, or diabetes, do not assume you are 'safe' just because you are taking medication. The study shows that most people on treatment still do not reach healthy target levels. You must actively engage with your healthcare provider to ensure your numbers are actually within the target range, and prioritize lifestyle changes like diet and exercise, as medication alone is often insufficient.

Even when primary risk factors (blood pressure, cholesterol, HbA1c, BMI) are successfully controlled through treatment, a significant proportion of patients (approx. 35-39%) remain at high cardiovascular disease risk.

Even if your doctor gets your blood pressure, cholesterol, or blood sugar under control, you are not necessarily 'out of the woods.' The study shows that about 1 in 3 people who successfully control these numbers still have a high risk of heart disease. To truly protect your heart, you must address ALL risk factors, including smoking, weight, and physical activity, not just the one your medication targets.

Lifestyle counseling, particularly written dietary advice and smoking cessation strategies, is poorly implemented in primary prevention clinical practice across Europe.

If you are seeing a doctor for prevention, do not rely on verbal advice alone. Ask for written dietary plans and smoking cessation strategies. The study shows that most patients do not receive these structured resources, which are crucial for making lasting lifestyle changes.

Metformin's primary glucose-lowering mechanism involves altering gut microbiota composition to increase butyrate and propionate production and enhance GLP-1 secretion, rather than solely acting via hepatic pathways.

If you take metformin, its effectiveness is partly driven by how it changes your gut bacteria to boost GLP-1. If you experience stomach issues, ask about delayed-release formulations (MetDR) which target the lower gut specifically, potentially reducing side effects while maintaining efficacy.

Sarcopenia, defined by low muscle mass and slow gait speed, is associated with a significantly increased risk of all-cause mortality in community-dwelling older adults.

If you are an older adult, maintaining your walking speed and muscle mass is crucial for longevity. You can assess your risk by checking if your gait speed is slower than 0.8 m/s or if you have low muscle mass. This condition, known as sarcopenia, significantly increases your risk of death, so it warrants attention and potential lifestyle interventions like resistance training.

Obesity, defined by BMI or waist circumference, does not modify the relationship between sarcopenia and all-cause mortality.

For older adults, having extra body fat does not cancel out the dangers of sarcopenia. Whether you are obese or not, having low muscle mass and slow walking speed increases your risk of death. Focus on maintaining muscle mass rather than just weight.

Dietary intake of choline, carnitine, and TMAO from foods like red meat, eggs, and marine fish is converted by gut bacteria into trimethylamine (TMA), which is then oxidized by the host enzyme FMO3 into trimethylamine N-oxide (TMAO), a metabolite implicated in cardiovascular disease and metabolic disorders.

Your gut bacteria convert nutrients from foods like red meat, eggs, and fish into TMA, which your liver turns into TMAO. High TMAO levels are linked to heart disease risk. To manage this, focus on dietary variety and gut health, as not all sources (like betaine) produce TMA, and individual microbiome differences affect how much TMAO you produce.

Fasting and calorie restriction upregulate UCP2 and UCP3 mRNA expression in human skeletal muscle and adipose tissue, suggesting a metabolic adaptation to energy deficit.

When you restrict calories, your body increases the expression of specific mitochondrial proteins (UCP2 and UCP3) in muscle and fat. This is a normal adaptation to fasting, not a sign that your metabolism is permanently broken. This upregulation happens similarly in both lean and obese individuals, suggesting the regulatory machinery is intact even in obesity.

TLR4 signaling is a key pathway for the progression of NAFLD, driven by circulating LPS from gut microbiota.

Focus on reducing gut permeability through diet (e.g., fiber, probiotics) to lower LPS levels, which may reduce liver inflammation via the TLR4 pathway.

Aging has a profound impact on the regulation of satellite cells in human skeletal muscle, potentially leading to a decrease in satellite cell number and function.

As you age, your satellite cells may not function as well, but you can still build muscle through exercise and proper nutrition. Focus on resistance training and a balanced diet to support muscle growth and adaptation.

Gut microbiota composition directly influences circulating levels of metabolites such as acetate, glutamine, and TMAO, which are associated with metabolic traits including insulin resistance, lipid profiles, and glucose tolerance.

Your gut bacteria produce metabolites that affect your blood lipids, glucose, and inflammation. While this paper doesn't prescribe a specific diet, it highlights that the types of bacteria in your gut are linked to metabolic health markers. Focusing on a diverse diet that supports beneficial bacteria (like those producing acetate) may support metabolic balance, though individual responses vary.

Higher abundance of Blautia is associated with higher levels of saturated and monounsaturated fatty acids, while lower abundance is associated with polyunsaturated fatty acids, suggesting a link between specific bacterial genera and lipid metabolism.

The type of fat in your diet may influence which bacteria thrive in your gut. A diet high in saturated fats might favor Blautia, while polyunsaturated fats might favor other taxa. This is a correlation, not a prescription, but it suggests dietary fats shape your microbial ecosystem.